Skip to main content
. 2013 Nov 15;188(10):1216–1223. doi: 10.1164/rccm.201303-0462OC

TABLE 1.

PATIENT CLINICAL CHARACTERISTICS

  Final Diagnosis
 
Hodgkin Lymphoma High-Grade NHL Low-Grade NHL Nonlymphoma Diagnosis Total
Total number
24
12
30
34
100
De novo lymphoma
22
11
18
1*
52
 Lymphoma follow-up
2
1
12
33
48
Median (range) age, yr
54 (24–84)
61 (25–85)
63 (59–85)
66 (25–88)
61 (24–88)
Male/female
12/12
5/7
18/12
16/18
51/49
Indication
 
 
 
 
 
 Mediastinal mass
8
1
1
0
10
 Mediastinal lymphadenopathy
16
11
29
34
90
  Isolated
11
8
14
1
34
  HIV positive
2
0
0
0
2
  Evaluation in known carcinoma
0
2
4
0
6
  Evaluation in known lymphoma
3
1
11
33
48
Lymph node stations
 
 
 
 
 
 Total
44
15
59
67
185
 2R/L
4
0
3
4
11
 4R/L
20
8
22
20
70
 7
12
4
19
15
50
 10-12R/L
8
3
15
28
54
Mean (range) lymph node size, cm
1.8 (0.5–4)
1.9 (0.9–4)
1.5 (0.5–3)
1.2 (0.5–2)
1.6 (0.5–4)
Mean (range) number of passes per lymph node 6.7 (2–13) 5.3 (3–9) 4.7 (2–11) 4.1 (2–10) 5.2 (2–12)

Definition of abbreviation: NHL = non-Hodgkin lymphoma.

*

False-positive diagnosis of probable non-Hodgkin lymphoma.

Refers to delineation of lymph node stations by endobronchial ultrasound based on the new International Association of Study of Lung Cancer lymph node map.